FENOFIBRATE

Product NDC: 68071-2540
11-digit product format: 680712540
Labeler code: 68071
Product ID: 68071-2540_e674720f-dc2a-0824-e053-2995a90a4cd5
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FENOFIBRATE
Dosage form: TABLET
Route: ORAL
Labeler: NuCare Pharmaceuticals,Inc.
Application: ANDA213864
Marketing category: ANDA
Marketing start: 2020-09-10
Marketing end: 0000-00-00
Substance: FENOFIBRATE
Active strength: 160 mg/1
Pharmacologic classes: Peroxisome Proliferator Receptor alpha Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68071-2540		I	Inactivated by FDA		2026-08-17
excluded package	package	68071-2540	68071-2540-9	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2540-9	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2540-9	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2540-9	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2540-9	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2540-9	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2540-9	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2540-9	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2540-9	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2540-9	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A213864-001	FENOFIBRATE	FENOFIBRATE	54MG	TABLET / ORAL	AB		2020-06-12
A213864-002	FENOFIBRATE	FENOFIBRATE	160MG	TABLET / ORAL	AB		2020-06-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A213864-001	AB
A213864-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 76 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A213864-001	FENOFIBRATE	54MG	TABLET / ORAL	AB	2020-06-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A213864-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	2020-06-12	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 76 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A213864-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213864-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213864-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213864-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213864-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213864-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213864-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213864-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213864-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213864-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213864-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213864-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213864-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213864-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213864-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213864-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213864-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213864-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213864-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213864-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213864-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213864-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213864-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213864-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213864-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213864-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213864-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213864-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A213864-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A213864-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A213864-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A213864-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A213864-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A213864-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A213864-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A213864-002	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A213864-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A213864-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A213864-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A213864-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
193bb7da-5c03-8f95-9048-23ef403846b0	Product name	3	20250616
fa35fb9a-7146-716b-13c8-bc1f60030232	Product name	9	20250114
cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07	Product name	8	20231212
53d5b6b7-785a-4500-9460-263c7f8424b8	Product name	5	20210105
ed9d55d4-85bd-0ee7-5b4a-b705646a3a66	Product name	9	20200708
36a239c8-03fb-0083-81af-6c1afb195671	Product name	1	20140508
a0296d70-ca85-018c-84e8-cf3f630976b7	Product name	1	20140508
f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68071-2540-9	2025-01-30	C162847	48780-1	2cef2736-93af-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use FENOFIBRATE TABLETS safely and effectively. See full prescribing information for FENOFIBRATE TABLETS FENOFIBRATE tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-2540-9	FENOFIBRATE	90 in 1 BOTTLE	TABLET	90		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2540	FENOFIBRATE TABLET [NUCARE PHARMACEUTICALS,INC.]	3	Legacy NDC, 1 package rows	20230715_cc85c6cc-7fd4-4013-e053-2a95a90aa5d1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FENOFIBRATE	FENOFIBRATE	REMEDYREPACK INC.	3b6c5ebd-a8bc-4502-8b66-f4e58914815b	2026-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	St. Mary's Medical Park Pharmacy	b92fb19a-d0df-426e-e053-2995a90ab379	2026-06-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	df9f67d6-3cd9-4f44-8020-2d6ef53c30b5	2026-05-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Preferred Pharmaceuticals Inc.	e573b3f1-5a4c-4a19-9f0f-ee797b379a08	2026-04-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	f443dd79-46da-4b02-8188-7417d39cf975	2026-03-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	REMEDYREPACK INC.	b79efcf4-6016-4a1f-b83f-be00baa25c21	2026-02-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Northwind Health Company, LLC	f7590970-c54d-24e9-e053-6294a90ac400	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	NorthStar RxLLC	3b448774-aebf-45fe-92f1-b8eca53cf09b	2025-09-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Major Pharmaceuticals	3f4e5db8-5bfb-4b24-8465-9757cbaad2be	2025-06-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Lifestar Pharma LLC	1da57e8c-3977-43e1-aa7e-229760203f7d	2025-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Bryant Ranch Prepack	d34f9fa3-39ae-4b8e-8f29-0d5c655c50b5	2023-03-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864
FENOFIBRATE	FENOFIBRATE	Proficient Rx LP	26f8f793-fb7a-4327-9441-d8737fe1ff11	2022-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213864 application number: ANDA213864

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U202363UOS	FENOFIBRATE	49562-28-9	FENOFIBRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
349287	fenofibrate 160 MG Oral Tablet	PSN	cc85c6cc-7fd4-4013-e053-2a95a90aa5d1	3
349287	fenofibrate 160 MG Oral Tablet	SCD	cc85c6cc-7fd4-4013-e053-2a95a90aa5d1	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68071-2540-9	68071254009	90 TABLET in 1 BOTTLE (68071-2540-9)	90 tablet	2021-09-21	0000-00-00	No	No	Current